Prevalence and Outcomes of COVID -19 Patients with Happy Hypoxia: A Systematic Review
- PMID: 36172621
- PMCID: PMC9512283
- DOI: 10.2147/IDR.S378060
Prevalence and Outcomes of COVID -19 Patients with Happy Hypoxia: A Systematic Review
Abstract
Background: In Coronavirus disease 2019 (COVID-19), some patients have low oxygen saturation without any dyspnea. This has been termed "happy hypoxia." No worldwide prevalence survey of this phenomenon has been conducted. This review aimed to summarize information on the prevalence, risk factors, and outcomes of patients with happy hypoxia to improve their management.
Methods: We conducted a systematic search of electronic databases for all studies published up to April 30, 2022. We included high-quality studies using the Newcastle-Ottawa Scale (NOS) tool for qualitative assessment of searches. The prevalence of happy hypoxia, as well as the mortality rate of patients with happy hypoxia, were estimated by pooled analysis and heterogeneity by I2.
Results: Of the 25,086 COVID-19 patients from the 7 studies, the prevalence of happy hypoxia ranged from 4.8 to 65%. The pooled prevalence was 6%. Happy hypoxia was associated with age > 65 years, male sex, body mass index (BMI)> 25 kg/m2, smoking, chronic obstructive pulmonary disease, diabetes mellitus, high respiratory rate, and high d-dimer. Mortality ranged from 01 to 45.4%. The pooled mortality was 2%. In 2 studies, patients with dyspnea were admitted to intensive care more often than those with happy hypoxia. One study reported that the length of stay in intensive care did not differ between patients with dyspnea and those with happy hypoxia at admission. One study reported the need for extracorporeal membrane oxygenation (ECMO) in patients with happy hypoxia.
Conclusion: The pooled prevalence and mortality of patients with happy hypoxia were not very high. Happy hypoxia was associated with advanced age and comorbidities. Some patients were admitted to the intensive care unit, although fewer than dyspneic patients. Its early detection and management should improve the prognosis.
Keywords: COVID −19; happy hypoxia; outcomes; prevalence.
© 2022 Bepouka et al.
Conflict of interest statement
The authors report no competing interests in this work.
Figures
Similar articles
-
Community-based care for the specialized management of heart failure: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(17):1-42. Epub 2009 Nov 1. Ont Health Technol Assess Ser. 2009. PMID: 23074521 Free PMC article.
-
Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis.Crit Care. 2022 May 23;26(1):147. doi: 10.1186/s13054-022-04011-2. Crit Care. 2022. PMID: 35606884 Free PMC article.
-
Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(5):1-47. Epub 2010 Apr 1. Ont Health Technol Assess Ser. 2010. PMID: 23074408 Free PMC article.
-
Mortality in patients with COVID-19 requiring extracorporeal membrane oxygenation: A meta-analysis.World J Clin Cases. 2022 Mar 16;10(8):2457-2467. doi: 10.12998/wjcc.v10.i8.2457. Epub 2022 Jan 16. World J Clin Cases. 2022. PMID: 35434060 Free PMC article.
-
Role of extracorporeal membrane oxygenation in pediatric cancer patients: a systematic review and meta-analysis of observational studies.Ann Intensive Care. 2022 Jan 29;12(1):8. doi: 10.1186/s13613-022-00983-0. Ann Intensive Care. 2022. PMID: 35092500 Free PMC article. Review.
Cited by
-
Retrospective longitudinal study on the long-term impact of COVID-19 infection on polysomnographic evaluation in patients with Prader-Willi syndrome.Orphanet J Rare Dis. 2024 Dec 13;19(1):461. doi: 10.1186/s13023-024-03447-9. Orphanet J Rare Dis. 2024. PMID: 39673054 Free PMC article.
-
Multifaceted functions of Drp1 in hypoxia/ischemia-induced mitochondrial quality imbalance: from regulatory mechanism to targeted therapeutic strategy.Mil Med Res. 2023 Oct 13;10(1):46. doi: 10.1186/s40779-023-00482-8. Mil Med Res. 2023. PMID: 37833768 Free PMC article. Review.
-
External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan.J Intensive Care. 2024 Feb 15;12(1):7. doi: 10.1186/s40560-024-00720-8. J Intensive Care. 2024. PMID: 38360681 Free PMC article.
-
Unraveling the Underlying Molecular Mechanism of 'Silent Hypoxia' in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway.J Clin Med. 2023 Mar 22;12(6):2445. doi: 10.3390/jcm12062445. J Clin Med. 2023. PMID: 36983445 Free PMC article. Review.
-
'Choose well' is not good advice to people in need of NHS care.Br J Gen Pract. 2023 Jul 27;73(733):360. doi: 10.3399/bjgp23X734529. Print 2023 Aug. Br J Gen Pract. 2023. PMID: 37500470 Free PMC article. No abstract available.
References
-
- World Health Organization. Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/. Accessed August 30, 2022.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous